Haven't had much time lately? Here's what you may have missed in the last few weeks.
Sign-up to receive the OncologyPRO alert
every 2 weeks.
New! e-Update on Gastric Cancer Treatment Recommendations
Find all the latest ESMO Guidelines
and
discover the ESMO Guidelines Slide Sets
!
For full access to all OncologyPRO content: daily medwireNews, ESMO books, slides and webcasts... and much more.
Become an ESMO member today!
19 Aug 2019
Individuals with metastatic colorectal cancer could benefit from increasing their weekly levels of physical activity
16 Aug 2019
US researchers pinpoint the specific postsurgical window associated with improved overall survival among patients with resected stage I–II pancreatic...
14 Aug 2019
Phase II findings support further investigation of adding the PI3K inhibitor taselisib to neoadjuvant endocrine therapy for stage I–III breast...
14 Aug 2019
A meta-analysis has highlighted the potential cardiovascular risks of combination BRAF–MEK inhibitor therapy in patients with melanoma
13 Aug 2019
Progression-free survival was comparable in patients with metastatic non-small-cell lung cancer positive for an EGFR mutation treated with erlotinib...
A. Lamarca reports on study results presented on pancreatobiliary cancers at ASCO 2019. She explains the importance of testing for BRCA gene mutation in pancreatic cancer patients and discusses the chemotherapy versus active symptoms control in second-line management of advanced/metastatic biliary cancer.
18-23 Jul 2019, Valencia, Spain
03-04 Jul 2019, Zurich, Switzerland
03-06 Jul 2019, Barcelona, Spain
27-28 Jun 2019, Zurich, Switzerland
18-23 Jun 2019, Lugano, Switzerland
14-15 Jun 2019, Barcelona, Spain
10-11 Jun 2019, Kazan, Russian Federation
17-18 May 2019, Valencia, Spain
10-11 May 2019, Zurich, Switzerland
07-08 May 2019, Zurich, Switzerland
02-04 May 2019, Berlin, Germany
26-27 Apr 2019, Lugano, Switzerland
13-14 Apr 2019, Hong Kong
12-13 Apr 2019, Prague, Czech Republic
12-17 Apr 2019, Sibenik, Croatia
